SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001356576-21-000010
Filing Date
2021-02-24
Accepted
2021-02-24 12:48:33
Documents
16
Period of Report
2021-02-24
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K supn-20210224.htm   iXBRL 8-K 37218
2 EX-99.1 ex99102-23x2021.htm EX-99.1 10096
8 image_01a.jpg GRAPHIC 5496
  Complete submission text file 0001356576-21-000010.txt   200232

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20210224.xsd EX-101.SCH 2436
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20210224_cal.xml EX-101.CAL 722
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20210224_def.xml EX-101.DEF 1659
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20210224_lab.xml EX-101.LAB 24274
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20210224_pre.xml EX-101.PRE 12658
9 EXTRACTED XBRL INSTANCE DOCUMENT supn-20210224_htm.xml XML 11105
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 21670639
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences